KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 102 filers reported holding KRYSTAL BIOTECH INC in Q3 2020. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $742 | +118.2% | 6,400 | +120.7% | 0.00% | +200.0% |
| Q2 2023 | $340 | +9.0% | 2,900 | -25.6% | 0.00% | – |
| Q1 2023 | $312 | -3.7% | 3,900 | -4.9% | 0.00% | -100.0% |
| Q4 2022 | $324 | -99.9% | 4,100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $285,000 | +5.9% | 4,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $269,000 | +3.9% | 4,100 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $259,000 | -4.8% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $272,000 | +34.0% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $203,000 | -23.4% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $265,000 | +178.9% | 3,900 | +69.6% | 0.00% | – |
| Q2 2020 | $95,000 | -4.0% | 2,300 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $99,000 | -22.0% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $127,000 | -19.6% | 2,300 | -50.0% | 0.00% | – |
| Q3 2019 | $158,000 | +71.7% | 4,600 | +100.0% | 0.00% | – |
| Q2 2019 | $92,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $53,700,000 | 4.14% |
| S Squared Technology, LLC | 85,215 | $5,113,000 | 2.93% |
| First Light Asset Management, LLC | 491,740 | $29,504,000 | 2.18% |
| Redmile Group, LLC | 1,675,036 | $100,502,000 | 1.22% |
| Nicholas Investment Partners, LP | 233,543 | $14,013,000 | 1.08% |
| HighMark Wealth Management LLC | 17,586 | $1,055,000 | 0.91% |
| DSAM Partners (London) Ltd | 87,608 | $5,256,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 101,044 | $6,063,000 | 0.54% |
| Hood River Capital Management LLC | 261,122 | $15,667,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 9,900 | $594,000 | 0.45% |